Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3741689013 | Product containing only natalizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3741690016 | Natalizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1129121000172113 | produit contenant seulement du natalizumab sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1152951000172112 | product dat enkel natalizumab in parenterale vorm bevat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only natalizumab in parenteral dose form (medicinal product form) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing only natalizumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only natalizumab in parenteral dose form (medicinal product form) | Has active ingredient | Natalizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only natalizumab in parenteral dose form (medicinal product form) | Is a | Product containing only natalizumab (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only natalizumab in parenteral dose form (medicinal product form) | Is a | Natalizumab-containing product in parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Natalizumab 20 mg/mL solution for injection | Is a | True | Product containing only natalizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR